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Abstract
Bacterial resistance to antibiotics has become an increasing threat, requiring not only the 
development of new targets in drug discovery, but more importantly, a better understanding of 
cellular response. In the current study, three closely related Escherichia coli strains, a wild type 
(MG1655), and an isogenic pair derived from the wild type (DPB635 and DPB636) are studied 
following exposure to sub lethal concentrations of antibiotic (norfloxacin) over time. In particular, 
genotype similarities between the three strains were assessed based on the lipid regulation 
response (e.g., presence/absence and up/down regulation). Lipid identification was performed 
using direct surface probe analysis (Matrix-assisted laser desorption/ionization, MALDI), coupled 
to high-resolution mass spectrometry (Fourier transform ion cyclotron resonance mass 
spectrometry, FT-ICR MS) followed by statistical analysis of variability and reproducibility across 
batches using internal standards. Inspection of the lipid profile showed that for the MG1655, 
DPB635 and DPB636 E. coli strains, a similar distribution of the altered lipids were observed after 
exposure to norfloxacin antibiotic (e.g., fatty acids and glycerol phospholipids are up and down 
regulated, respectively). Additionally, variations in the lipid distribution resemble the extent to 
which each strain can combat the antibiotic exposure. That is, the topA66 topoisomerase I 
mutation of DPB636 translates into diminished response related to antibiotic sensitivity when 
compared to MG1655 and the DPB635 strains.
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SUPPORTING INFORMATION:
Additional supporting information has been submitted. Supporting information includes: total lipid counts for each strain 
(supplemental Tables 1–3), common lipid distribution among the three strains (supplemental Table 4), MG1655 lipids as a function of 
antibiotic exposure (supplemental Tables 5–8), DPB635 lipids as a function of antibiotic exposure (supplemental Tables 9–12), and 
DPB636 lipids as a function of antibiotic exposure (supplemental Tables 13–16). In addition, the performance of the lipid internal 
standard has been presented to demonstrate the influence of matrix effects within the E. coli lipid samples.
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INTRODUCTION
Lipids are an integral component to cells, involved in energy storage processes and in 
maintaining structural integrity[1]. Biological pathways that utilize lipids have been 
associated with tumor progression[2], neurological disorders[3] and infections[4]; and more 
recently, it has been shown that changes in the lipid profiles can be used as markers for 
cellular regulation processes[5]. In particular, evidence suggests that SOS cell response[6] to 
external stress conditions (e.g., antibiotic treatment) triggers gene expression changes[7], 
cell mutations[8] and macromolecular differentiation which results in bacterial resistance. At 
the cellular level, these changes translate into morphological (e.g., cell membrane[9]) and 
physiological changes, suggesting that the SOS cell response can be correlated with the lipid 
composition and localization.
Over the last decade, significant advances in the development of high throughput analytical 
techniques have permitted the characterization of lipid profiles from complex biological 
targets[10] and the study of antibiotic response on surfaces using mass spectrometry[11–14]. 
While classical lipid analysis includes lengthy extraction, pre-fractionation followed by 
chromatographic separation (e.g., GC and LC) and mass spectrometry identification[15], 
current efforts progress towards the development of in situ lipid profiling tools combining 
surface probes (e.g., DESI, MALDI and TOF-SIMS) with fast, gas phase, post-ionization 
separation techniques[16–26]. In addition, when complemented with high-resolution mass 
spectrometry, the analyses of biological surfaces can take advantage of the high mass 
accuracy for direct lipid identification [27–29]. Recent work has shown that lipid 
quantification is possible when using internal standards[30, 31]
In the present paper, we utilize the advantages of high-resolution mass spectrometry 
combined with a direct surface probe – matrix-assisted laser desorption ionization coupled 
to Fourier transform ion cyclotron resonance mass spectrometry (MALDI FT-ICR MS) – for 
the analysis of the SOS cell response of three Escherichia coli (E. coli) strains as a 
preliminary step towards single cell in situ lipid profiling. In particular, SOS cell response is 
studied for the case of a wild type (MG1655) and two isogenic strains derivatives of the wild 
type (DPB635 and DPB636) as a function of the concentration and the exposure time of the 
antibiotic norfloxacin, a fluoroquinolone. Bacterial SOS response to DNA damage by 
quinolone action has been shown to lead to an increase in general antibiotic resistance.[32, 
33] When compared to strains MG1655 and DPB635, strain DPB636 exhibits norfloxacin 
hypersensitivity (manuscript in preparation) as a result of the topA66 mutation in the C-
terminal domain of topoisomerase I[34]; the latter will be used to identify specific lipid 
changes in the isogenic strains that may be correlated with antibiotic sensitivity. 
Topoisomerase I is present in all bacteria, and has been shown to be a promising target for 
discovery of novel antibacterial drugs.[35–37]
EXPERIMENTAL SECTION
Cell growth conditions
The experimental design used to generate the subset of cultures used in this study has been 
depicted in Scheme 1. Briefly, E. coli strains MG1655 (K-12 wild-type), DPB635 (MG1655 
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zci-2250::mini-kan), DPB636 (MG1655 topA66 zci-2250::mini-kan), were obtained from 
the Yale Coli Genetic Stock Center (New Haven, CT). Cultures of the three E. coli strains 
were grown overnight in Luria-Bertani (LB) growth medium in a 37 °C shaker at 200 rpms 
(culture I). A 1:500 inoculation of culture I was added to 500 mL LB in a 1000-mL 
Erlenmeyer flask (strainstock). Culture A was grown at 37 °C, 200 rpms to an OD600 = 0.5. 
From culture A, 75 mL aliquots were transferred to three 250-mL Erlenmeyer flasks, 
denoted culture B, C and D, respectively. The norfloxacin used in the studies was diluted 
from a 10 µg/mL stock in 0.1 M NaOH in order to obtain sublethal concentrations of 25 
ng/mL and 50 ng/mL antibiotic in flasks two and three, respectively. Culture B contained 
only 0.1M NaOH to account for the presence of this solvent in cultures C and D. Flasks 
were placed back in the shaker. At 30 and 60 minute time intervals, 30 mL samples were 
taken from cultures B (straincontrol), C and D (strainstress) in order to evaluate the antibiotic 
response as a function of time exposure and concentration. Samples were then centrifuged 
for 10 minutes at 3000 rpms to generate a cell pellet. The cell pellets were washed with 5 
mL of 10 mM EDTA (pH 8.0) and 50 mM glucose solution[38], centrifuged and washed 
with 5 mL autoclaved water. Finally cell pellets were frozen at −80 °C. Growth media was 
made in large batches and other steps were taken to reduce batch variation in lipid profile 
that can be influenced by growth conditions [39–41].
MALDI-FTICR-MS preparation and analysis
Frozen cell pellets were reconstituted in 15 mL of a 1:1:1 water (0.1% TFA) : ethanol : 
dichloromethane solution[39] and left for 18–24 hours to extract the lipids from the total cell 
material. The lipid layer was concentrated to 1 mL using a CentriVac system. A 10 mg/mL 
2,5-dihydroxybenzoic acid (Sigma-Aldrich Co. LLC, St. Louis, MO) in an analytical grade 
90 % methanol, 0.1 % FA matrix-solvent system was used as a MALDI matrix. 
Reproducibility of the analysis was corrected using known concentration of an internal lipid 
standards mixture of (catalog numbers 840635P, 850745P, 840455P, 840036P, 850141P,
700085, 700000P, LM-6002, LM-6000, Avanti Polar Lipids, Inc., Alabaster, Alabama). A 1 
µL volume of a 1::1 analyte:internal standard mix solution was spotted on a stainless steel 
MALDI target and the MALDI matrix was sublimated to guarantee homogeneity across the 
spot. Each sample was analyzed in triplicate. Analysis was conducted using a Bruker Solarix 
7.0T FT-ICR MS equipped with a SmartBeam II laser for MALDI analyses (Bruker 
Daltonics, Inc., Billerica, MA). The instrument was externally calibrated using a tuning mix 
standard (Tunemix, G2421A, Agilent Technologies, Santa Clara, CA) under electrospray 
ionization conditions in both positive and negative modes (< 1 ppm mass accuracy). Internal 
lipid standards and previously reported lipids were used as MALDI internal calibration post 
analysis [39, 42] Multiple replica (typically, 5 measurements) of positive and negative mode 
MALDI spectra were acquired for each experimental condition. The wash solutions, growth 
media and matrix solutions were run as controls for each batch. Six batches of each E. coli 
strain were analyzed without antibiotic in order to characterize similarities and differences 
between the strains. Three batches of the antibiotic study were utilized to evaluate the 
reproducibility of the stress response of each strain.
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Statistical analysis
The data processing workflow has been outlined in Scheme 2. In particular, this workflow 
has been adapted from reference [15] and determines statistically significant lipids using a p-
value = 0.05 and an intensity fold change following a student’s t-test. An The criteria for 
significant fold change was based on the reproducibility of the internal standards as a 
function of the conditions. In particular, matrix effects observed did not exceed a fold 
change of two, however to ensure minimal, if any, bias in the trends reported, a fold change 
of three was utilized to compensate for the variation in lipid standard reproducibility 
encountered in all samples. A bucketing approach was used to generate the t-test variables 
by dividing each mass spectrum into 5 mDa intervals to yield a single intensity value paired 
with a mass-to-charge unit using ProfileAnalysis (Bruker Daltonics, Inc., Billerica, MA). 
Each bucket list was normalized to the sum of the bucket values in the mass spectrum.
Comparisons were conducted based on total differences regardless of the analysis mode in 
which the lipid molecular ion was detected. Lipids were assigned from the LIPIDMAPS 
database[43] using a 5 ppm tolerance. Potential adducts were considered in the database 
search; that is [M+H]+, [M+Na]+ and [M+K]+for positive mode, and [M-H]−, [M-2H+Na]− 
and [M-2H+K]− for negative mode. The neutral lipid mass was used for trend comparison 
regardless of the molecular ion detected. All eight lipid categories (as grouped by 
LIPIDMAPS) were considered in the database search and lipid candidate structures were 
proposed based on the chemical formula. The complexity of the sample (i.e., multiple lipid 
signals at the level of nominal) limited the possibility to perform MS/MS experiments for 
secondary confirmation.
Following the procedure outline in Scheme 2, common and characteristic lipids between the 
three strains were determined. The extent of lipid differentiation between the three strains 
were determined from the total lipid assignments (Totalstock) generated for each strain (see 
supplemental Tables 1–3 for more details). Here after, a characteristic and a common lipid 
refers to a lipid that was detected in only one strain or in at least two/three strains, 
respectively. The number of batches (out of 6 total) in which the lipid was encountered can 
be used to assess the significance of the lipid when determining characteristic lipids among 
the strains.
For the case of SOS cell response, statistically significant lipid changes associated with the 
presence of norfloxacin were categorized on the basis of intensity fold change as up (↑) or 
down (↓) regulated. Lipids that are considered up or down regulated as a result of an absence 
(not detection either in the initial or final state) have been designated by ↑* or ↓*. All 
statistical comparisons have been made using the total lipid lists for each strain as described 
in scheme 2 (i.e., Totalstock, Totalcontrol and Totalstress). Each stress condition is comprised 
of a time exposure (30 or 60 minutes) and an antibiotic concentration (25 ng/mL or 50 
ng/mL) component; these results in four separate stress-related lipid comparisons per strain 
(see supplemental Tables 5–16 for more detail). In addition, to account for the influence of 
solvent, in particular the NaOH contribution to changes in the lipid profile following 
exposure to the norfloxacin antibiotic, lipids up or down regulated as a result of the stock vs. 
control comparison were removed if encountered in other stock vs. antibiotic comparisons. 
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That is, the listed lipids, either ↑, ↑*, ↓ or ↓* are only representative of the interaction of the 
antibiotic with the E. coli cell response.
RESULTS AND DISCUSSION
Lipid-related differentiation between the MG1655, DPB635 and DPB636 E. coli strains can 
be observed from the MALDI FT-ICR MS analysis (see Figure 1). The three strains are 
closely related which translates into more common lipids than characteristic lipids for the 
comparison. Inspection of the common lipid IDs show that most of the lipids correspond to 
fatty acyls, FA (424 of 1364 lipids) and glycerophospholipids, GP (328 of 1364), while 
other lipid classes are observed in lower abundances (see Table 1 and supplemental Tables 
1–4). The higher mass accuracy and resolution of the MALDI FT-ICR MS yielded more 
lipid IDs than previously reported by MALDI-TOF-MS studies of E.coli identification 
and/or differentiation. [12,15] This could also be the result of the preconcentration step 
incorporated into sample preparation, see scheme 1. In particular the current data is in good 
agreement of previous GP assignments and MALDI-TOF-MS reported lipids were also 
encountered as common lipids for the three strains studied here[39].
Genotype similarities between the MG1655, DPB635 and DPB636 strains can be observed 
from the analysis of common and characteristic lipids between two and all three strains (see 
Table 1). As expected, there is a large number of common lipids between the three strains 
(over 2000 lipids). An interesting observation comes from the analysis of lipids common to 
two strains (e.g., MG1655∩DPB635) vs common to two strains and not observed in the third 
one (e.g., MG1655∩DPB635ΔDPB636). Inspection of Table 1 shows that common lipids 
are correlated with the genotype similarity; that is, for example, MG1655 has more common 
lipids with DPB635 (not observed in DPB636) than with DPB636, suggesting that initially, 
prior to exposure to stress, the topA66 mutation does not play a significant role in lipid 
expression.
Further inspection of the characteristic lipids for each strain showed that the most abundant 
classes were common to the three strains (see Table 1). In particular, the larger abundance of 
fatty acyls (FA), sterols (ST) and glycerophospholipids (GP) relative to polyketides (PK) 
and saccharolipids (SL) suggesting that these classes may be used as lipid markers for each 
strain. It should be noted that while common lipids were detected in multiple batches, 
characteristic lipids were usually detected in low abundance, and encountered in fewer 
batches (see supplemental Tables 1–3 for details). For instance, at a mid-log point in growth 
(OD600 = 0.5) under standard laboratory conditions the genetic differences between strains 
did not yield large changes in the lipid profile obtained with this analysis. The differences in 
abundance between common and characteristic lipids suggests that common lipids are part 
of cellular processes, cell membranes and biological pathways that transcend the difference 
between the E. coli strains studied here. Moreover, characteristic lipids are likely involved in 
processes that result from genotype expression.
Lipid response resulting from the exposure to norfloxacin was also studied for all three 
strains (see example in Figure 2 for MG1655). Inspection of Figure 2 shows that following a 
30 minute exposure to norfloxacin, the MG1655 strain demonstrates a lipid response to the 
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presence of the antibiotic, resulting in an increase in the number of lipids that are up 
regulated in comparison to the strain stock (eliminating lipids from the control culture). 
However, following a 60 minute exposure, the spectra showed a large increase in the 
number of down regulated lipids (15 vs. 165 lipids at t= 30 and 60 minutes, respectively). 
Previous work has established that treatment of the MG1655 strain with 50 ng/mL 
norfloxacin was sufficient to induce multidrug resistance[44], which suggest that the 
changes in lipid composition are derived from a global cell response mechanism (e.g., cell 
membrane integrity[45] and cell division mechanism[46]).
The lipid response as a function of norfloxacin concentration and exposure has been 
summarized in Figure 3 for all the three strains. For the MG1655 strain, a general trend was 
observed in that down regulation was amplified at the later time regardless of the antibiotic 
concentration. However, the isogenic strains responded differently than the wild type 
(MG1655). For example, if cell response is evaluated by changes in up/down regulated 
lipids under stress conditions, data presented in Figure 3 suggest that DPB635 is capable of 
exhibiting a prolonged response (similar to MG1655 at low concentration and early time) by 
means of the lipid up regulation that extends to higher antibiotic concentrations and the 
longer duration of exposure. Furthermore, the distribution of the lipid profile for the 
DPB636 strain suggest that although the cells exhibit a similar trend in up regulation to the 
DPB635, most likely a result of the mini-kan transposon present in the isogenic strains that 
is absent in MG1655 [47], the hypersensitivity of DPB636 to norfloxacin is reiterated by the 
lower number of lipids influenced by the antibiotic (↑, ↑*, ↓, and ↓*) that predominates in 
the culture. This results in a deficiency in adaptation following norfloxacin exposure. The 
topA66 mutation in topoisomerase I that differs between the isogenic strains can also be the 
source for hypersensitivity observed in the DPB636 strain. Detailed information regarding 
the lipids detected under the stress conditions for each strain can be found in the 
supplemental tables 5–16.
Class specific lipid changes were analyzed as a function of the norfloxacin exposure (see 
Table 2). The fewer number of both up and down regulated lipids observed for the DPB636 
strain following norfloxacin exposure can also be attributed to cell death as a result of 
hypersensitivity of the strain to antibiotics. Inspection of Table 2 shows that for all three 
strains, changes in the up regulated lipids result in an increase in the number of fatty acyls, 
whereas down regulated lipids are predominantly glycerophospholipids, two of the most 
abundance lipid classes detected in E. coli[48, 49]. It is known that fatty acyls serve as 
building blocks for other more complex lipid groups[50] and their up regulation may be 
associated to degradation or metabolism of proteins, carbohydrates or sugars[50]. Moreover, 
when up regulation is coupled with phospholipid depletion, a more complex cell response 
mechanism may be occurring. For example, fatty acids can be used as starting material in 
the production of phospholipids[51]and therefore an initial increase in fatty acyl production 
following GP down regulation could imply a combative response in the cell to compensate 
for changes in membrane integrity. Phospholipids comprise the inner monolayer of the outer 
membrane and also the bilayer of the inner membrane[48]. Changes in the phospholipids, in 
this case an overall down regulation, could imply that cell integrity has been compromised 
with higher concentration or duration of exposure. Depletion in phospholipids could also 
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imply that the phospholipids have been metabolized or were used as other intermediates to 
adapt the cellular stress response imposed by the antibiotic as a function of concentration 
and time. Two main classes of phospholipids, phophatidylglycerols (PG) and 
phosphatidylethanolamines (PE), have been shown to be involved in the posttranslational 
modification of lipoproteins[48] that are associated with both the inner monolayer of the 
outer membrane. This could indicate an additional form of response that lipid down 
regulation can be correlated to. The two processes in conjunction could imply a change in 
gene regulation and proteomic composition [49, 52]. Previous work on Canduda albicans 
fungus[5] has shown that changes in lipid distribution (e.g., PGs in the antibiotic resistant 
isolates) coincide with the cell combative changes, the onset of antibiotic resistance and a 
change in membrane integrity[5].
CONCLUSIONS
Lipid profiles of three closely related E.coli strains were monitored using high resolution 
mass spectrometry and statistical analysis using internal lipid standards. Results showed that 
the present methodology permits the identification of the cell strain as well as insight into 
SOS response. This was accomplished using both the inspection of common and specific 
lipids to each strain and by using trends in up/down regulated lipids as a function of the 
norfloxacin antibiotic exposure. For the MG1655, DPB635 and DPB636 E. coli strains, a 
similar distribution of the altered lipids, FAs up regulated and GPs down regulated, were 
observed. The shift in the lipid distribution resembles the extent to which each strain can 
combat the antibiotic exposure. Results also suggest that the topA66 topoisomerase I 
mutation of DPB636 translates into diminished response related to antibiotic sensitivity 
when compared to MG1655 and the DPB635 strains. Despite the complexity of the 
biological samples, the workflow and methodology presented here permits the analysis of 
cell strains during the SOS response for lipid differentiation. In particular, high resolution 
mass spectrometry when coupled to a surface interrogation probe provides in situ detection 
of lipid differences for closely related E. coli strains.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Typical positive mode MALDI FT-ICR MS spectra for MG1655 (top), DPB635 (middle) 
and DPB636 (bottom). Peaks labeled with a (*) correspond to characteristic lipids detected 
for the particular E. coli strain. The blue dashed lines depict lipids common to all three 
strains.
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Figure 2. 
Positive mode MALDI FT-ICR MS spectra for MG1655 stock (top), 50 ng/mL norfloxacin 
30 minute exposure (middle) and 50 ng/mL norfloxacin 60 minute exposure (bottom). Peaks 
labeled with (*) and (♦) correspond to up and down regulated lipids, respectively.
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Figure 3. 
Total number of lipids up or downregulated as a function of norfloxacin dose and time 
exposure for MG1655, DPB635 and DPB636. Values above each column correspond to the 
number of ↑:↑* lipids or ↓:↓* lipids for each strain and condition. The asterisk (*) 
corresponds to lipids that are up or down regulated on the basis of an absence (not 
detection).
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Scheme 1. 
E. coli growth conditions and antibiotic study preparation and analysis workflow. Sample 
(A) refers to the strain stock culture, (B) NaOH control culture, (C) low dose antibiotic 
culture + NaOH and (D) high dose antibiotic culture + NaOH. Cultures (B), (C) and (D) had 
samples pulled at two time intervals – 30 minutes and 60 minutes following splitting from 
(A).
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Scheme 2. 
Workflow of MALDI-FTICR-MS data processing utilized for E. coli strain comparison 
using an internal standard (IS). The asterisk (*) corresponds to lipids that are up or down 
regulated on the basis of an absence (not detection) in the other sample being compared.
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Table 1
Distribution of common (∩) and characteristic (Δ) lipids between MG1655, DPB635 and DPB636 strains.
Strain PR FA ST GL GP SP SL PK Total
MG1655ΔDPB635ΔDPB636 121 200 142 168 651 67 7 3 1359
DPB635ΔMG1655ΔDPB636 21 49 33 40 175 19 2 339
DPB636ΔMG1655ΔDPB635 28 52 62 18 115 18 1 1 295
MG1655∩DPB635∩DPB636 135 436 244 127 745 235 6 11 1939
MG1655∩DPB635 167 496 289 168 932 286 6 11 2355
MG1655∩DPB636 176 497 303 208 1011 331 10 11 2547
DPB635∩DPB636 147 476 279 155 801 331 8 11 2208
MG1655∩DPB635ΔDPB636 173 298 228 225 961 160 7 4 2056
MG1655∩DPB636ΔDPB635 41 61 59 81 266 96 4 0 608
DPB635∩DPB636ΔMG1655 59 124 98 113 406 182 3 2 987
FA = fatty acyls, PR = Prenol lipids, SP = Sphingolipids, ST = Sterol lipids, GP = Glycerophospholipids, PK = polyketide lipids, GL = 
Glycerolipids and SL = Saccharolipids
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